e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The status of venous vasodilator, vasoconstrictors in high-altitude pulmonary edema susceptible subjects under hypoxic exposure
N. Kobayashi, M. Hanaoka, Y. Droma, K. Kogashi, K. Urushibata, K. Kubo (Matsumoto, Japan)
Source:
Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Session:
Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Session type:
Thematic Poster Session
Number:
4532
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kobayashi, M. Hanaoka, Y. Droma, K. Kogashi, K. Urushibata, K. Kubo (Matsumoto, Japan). The status of venous vasodilator, vasoconstrictors in high-altitude pulmonary edema susceptible subjects under hypoxic exposure. Eur Respir J 2010; 36: Suppl. 54, 4532
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics
Source: Eur Respir J 2012; 40: 1401-1409
Year: 2012
Dexamethasone and tadalafil prophylaxis prevents both excessive pulmonary constriction and high altitude pulmonary edema in susceptible subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 110s
Year: 2004
Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude
Source: Eur Respir J 2005; 25: 545-551
Year: 2005
High-altitude disease
Source: Respipedia Article
Year: 2017
Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Dag-dependent regulation of trpc6 in hypoxic pulmonary vasoconstriction
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
Effects of Sildenafil on hypoxic pulmonary vasoconstriction in dogs
Source: Eur Respir J 2001; 18: Suppl. 33, 490s
Year: 2001
Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
Source: Eur Respir J 2002; 20: 332-338
Year: 2002
Haemodynamics during vasodilator test comparing urapidil and nicardipine to NO in pulmonary arterial hypertension
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002
Pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 892-905
Year: 2003
The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Acute pulmonary vasoreactivity to beraprost in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002
Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2009; 33: 1354-1360
Year: 2009
Increase of oxidative stress and pulmonary arterial inflammatory remodeling under high-flow conditions in experimental pulmonary hypertension
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017
Year: 2017
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept